Ubs Group Ag Delcath Systems, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 1,521 shares of DCTH stock, worth $14,738. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,521

Previous 9,402 83.82%

Holding current value

$14,738

Previous $78,000 83.33%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.36 - $11.0 $58,004 - $86,691	-7,881 Reduced 83.82%	1,521 $13,000
Q2 2024 Aug 13, 2024	BUY	$4.47 - $8.37 $38,459 - $72,015	8,604 Added 1078.2%	9,402 $78,000
Q1 2024 May 13, 2024	BUY	$3.72 - $5.09 $2,957 - $4,046	795 Added 26500.0%	798 $3,000
Q4 2023 Feb 09, 2024	BUY	$2.25 - $4.17 $2 - $4	1 Added 50.0%	3 $0
Q3 2023 Nov 09, 2023	SELL	$3.12 - $5.85 $65 - $122	-21 Reduced 91.3%	2 $0
Q2 2023 Aug 11, 2023	SELL	$5.38 - $7.96 $4,330 - $6,407	-805 Reduced 97.22%	23 $0
Q1 2023 May 12, 2023	SELL	$3.46 - $6.0 $8,546 - $14,820	-2,470 Reduced 74.89%	828 $4,000
Q4 2022 Feb 08, 2023	BUY	$2.59 - $3.71 $8,534 - $12,224	3,295 Added 109833.33%	3,298 $11,000
Q1 2022 May 16, 2022	SELL	$5.64 - $7.95 $8,335 - $11,750	-1,478 Reduced 99.8%	3 $0
Q4 2021 Feb 14, 2022	BUY	$7.2 - $11.72 $3,247 - $5,285	451 Added 43.79%	1,481 $11,000
Q3 2021 Nov 15, 2021	BUY	$8.44 - $12.65 $8,676 - $13,004	1,028 Added 51400.0%	1,030 $11,000
Q2 2021 Aug 13, 2021	SELL	$9.54 - $15.1 $9,892 - $15,658	-1,037 Reduced 99.81%	2 $0
Q1 2021 May 12, 2021	BUY	$12.42 - $23.81 $12,891 - $24,714	1,038 Added 103800.0%	1,039 $13,000
Q4 2020 Feb 11, 2021	SELL	$10.55 - $18.69 $10,961 - $19,418	-1,039 Reduced 99.9%	1 $0
Q3 2020 Nov 12, 2020	BUY	$8.8 - $12.84 $4,083 - $5,957	464 Added 80.56%	1,040 $12,000
Q2 2020 Jul 31, 2020	BUY	$7.31 - $13.0 $4,210 - $7,488	576 New	576 $6,000

Others Institutions Holding DCTH

# of Institutions

Shares Held

7.62M

Call Options Held

198K

Put Options Held

41.7K

View Full List

About DELCATH SYSTEMS, INC.

Ticker DCTH
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 8,597,680
Market Cap $83.3M
Description
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...

More about DCTH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account